All In MedTech

Device Trial Radar · NCT06018194

ELUCIDATE FFRct Study

The ELUCIDATE FFRct Study

Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

439

Actual

Start

Sep 1, 2023

Primary completion

Jul 28, 2025

Study completion Jul 28, 2025

Sponsor

Lead sponsor
Elucid Bioimaging Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 30, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate the diagnostic accuracy of a novel plaque-based coronary CT angiography (CCTA) fractional flow reserve (FFRct) software device for the estimation of invasive fractional flow reserve (FFR). Researchers will compare the Elucid plaque-based FFRct analysis to invasively measured FFR in patients who have previously undergone CCTA and invasively assessed FFR.

Conditions

  • Coronary Artery Disease

Interventions

  • ElucidVivoDevice

    Plaque morphology characterization on coronary CTA for predicting fractional flow reserve (FFRct)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity of FFRct versus invasive FFR for detecting invasive FFR ≤ 0.80Time frame: 1 day

1 more outcomes with a free account

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Cardiovascular Medical Group of Southern California

    Beverly Hills, California

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.